D-1446-2016 Class III Terminated
FDA drug recall D-1446-2016 was initiated by Sun Pharmaceutical Industries, Inc. on Jun 27, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Mar 27, 2018). Affected quantity: 16,085 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 27, 2016
- Initiation Date
- Jun 27, 2016
- Termination Date
- Mar 27, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16,085 bottles
Product description
buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
Lot JKN3477A, exp 07/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1446-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026